Last reviewed · How we verify

NCT07504692: EspertaMente

Biodiversity and Human Functioning Following Acquired Cerebrovascular Lesions - Phase 1

Completed Last updated 1 April 2026
What this trial tests

trial in Stroke in 150 participants. Completed in 30 November 2025.

Timeline
26 March 2025
Primary endpoint
30 September 2025
30 November 2025

Quick facts

Lead sponsorDr. Franco Molteni
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date26 March 2025
Primary completion30 September 2025
Estimated completion30 November 2025
Sites3 locations across Italy

Conditions studied

Sponsor

Dr. Franco Molteni

Who can join

5 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to investigate the impact that the set of factors to which a post-stroke person is exposed during daily life can have on their health. The study will examine the totality of conditions, known as the "exposome," which include biological, environmental, social, and lifestyle factors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07504692.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing